Company News in the Life Science Industry

»

Reset 

ESTA Reaches One Million Motiva Implants Milestone

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  Establishment Labs S.A.

CooperCompanies Announces Fourth Quarter and Full Year 2019 Results

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  The Cooper Companies, Inc.

Autolus Therapeutics Announces Conference Call to Review Clinical Data for Programmed T Cell Therapy Pipeline Presented at the 2019 ASH Annual Meeting

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  Autolus Therapeutics plc

Segra enters into Strategic Plant Genotyping and Tissue Culture Agreement with Sugarbud

Read more ››
By: GlobenewsWire - 05 Dec 2019

NGM Bio Announces Appointment of Shelly Guyer to Board of Directors

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  NGM Biopharmaceuticals, Inc.

Iscalimab (CFZ533) Update

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  XOMA Corporation

Galera Therapeutics Announces Publication of GC4419 Data in the Journal of Clinical Oncology

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  Galera Therapeutics, Inc.

Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Employees in Genmab

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  GeneNews Limited

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  GeneNews Limited

BioArctic's Partner Eisai Presents Data from the Ongoing BAN2401 Phase 2b Extension Study in Early Alzheimer's Disease

STOCKHOLM, Dec. 5, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that data from the ongoing BAN2401 Phase 2b open-label extension study in early Alzheimer's disease patients was presented by Eisai at the Clinical Trials in Alzheimer's Disease (CTAD) conference... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019
Related companies:  BioArctic AB

Modern Pathology Welcomes New Editor-In-Chief

PALM SPRINGS, Calif., Dec. 5, 2019 /PRNewswire/ -- The United States and Canadian Academy of Pathology is pleased to welcome George J. Netto, MD of The University of Alabama at Birmingham as the new Editor-in-Chief of its scientific journal, Modern Pathology. Dr. Netto will take over... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

Global Metabolic Partnering Analysis 2014-2019 by Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

RB and Evolve BioSystems Team Up to Advance Infant Gut Health

PARSIPPANY, N.J. and DAVIS, Calif., Dec. 5, 2019 /PRNewswire/ -- Today RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve BioSystems' infant probiotic. The partnership leverages assets and expertise from both companies to drive scale in messaging directly to consumers... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019
Related companies:  RBC Capital Markets | RBF, Advisors & Accountants | RBC Life Sciences | EVOLVE BIOSYSTEMS, INC.

Sierra Tucson Introduces Outpatient Services

TUCSON, Ariz., Dec. 5, 2019 /PRNewswire/ -- Sierra Tucson, an international leader in behavioral, mental and integrated healthcare, is now offering outpatient services for both its residents who have completed residential care, and others in recovery looking for continuing care support for mood... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

Global Seasonal Influenza Vaccines Drug Market Analysis & Forecast Report 2019: Universal Vaccines will have a Market Share of 18% and Sales of $1.15B in the 8MM by 2028

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

ACGME Launches AWARE Well-Being Resources

CHICAGO, Dec. 5, 2019 /PRNewswire/ -- The ACGME has released resources specifically designed for residents, faculty members, and graduate medical education (GME) programs and institutions to promote well-being, mitigate the effects of stress, and prevent burnout. The Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

FDA approves first generics of Gilenya

SILVER SPRING, Md., Dec. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.

Read more ››
By: PR Newswire Association LLC. - 05 Dec 2019
Related companies:  U.S. Food and Drug Administration

EIP Pharma Announces Presentation of Phase 2b Clinical Trial Results of Neflamapimod in Early-stage Alzheimer's Disease at Clinical Trials in Alzheimer's Disease (CTAD) meeting

BOSTON, Dec. 5, 2019 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019
Related companies:  EIP Pharma, Inc.

Global Bioinformatics Partnering Directory 2019: Deals and Agreements by the World's Leading Healthcare Companies

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

Global Orphan Diseases Partnering Directory 2019: Deals & Trends by Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies